Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy

NCT02814110 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Increase Muscle Strength in Patients With Muscular Dystrophy

Interventions

DRUG: Granulocyte colony-stimulating factor (Filgrastim)

Sponsor

Medical University of Bialystok